Literature DB >> 18674479

Peripheral arterial disease: diagnosis and management.

Faisel A Arain1, Leslie T Cooper.   

Abstract

Peripheral arterial disease is a common but underdiagnosed and undertreated disorder with substantial morbidity and mortality. The pathophysiology of peripheral arterial disease and the risk factors for developing it are similar to those for atherosclerotic disease occurring at other sites. Peripheral arterial disease can be diagnosed accurately with simple, noninvasive, office-based tests that measure the severity of the disease and provide valuable prognostic information. Optimal medical therapy includes a supervised exercise program, tobacco cessation, and modification of treatable risk factors. Cilostazol can improve pain-free and peak walking distances in patients with intermittent claudication. As a general rule, patients with lifestyle-limiting claudication who do not respond to medical management or those with critical limb ischemia should be referred to a vascular specialist for consideration of revascularization.

Entities:  

Mesh:

Year:  2008        PMID: 18674479     DOI: 10.4065/83.8.944

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

1.  Recombinant human interleukin-11 treatment enhances collateral vessel growth after femoral artery ligation.

Authors:  Julius Aitsebaomo; Siddharth Srivastava; Hua Zhang; Sushmita Jha; Zhongjing Wang; Stephan Winnik; Anka N Veleva; Xinchun Pi; Pamela Lockyer; James E Faber; Cam Patterson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

Review 2.  Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease.

Authors:  Kyung-Bok Lee; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

3.  Platelet-derived miR-92a downregulates cysteine protease inhibitor cystatin C in type II diabetic lower limb ischemia.

Authors:  Yunfeng Zhang; Qiang Guan; Xing Jin
Journal:  Exp Ther Med       Date:  2015-04-01       Impact factor: 2.447

Review 4.  Advances in non-contrast quiescent-interval slice-selective (QISS) magnetic resonance angiography.

Authors:  R R Edelman; M Carr; I Koktzoglou
Journal:  Clin Radiol       Date:  2018-01-12       Impact factor: 2.350

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.